These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16025050

  • 21. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 23. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
    Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S.
    Transpl Infect Dis; 2006 Jun; 8(2):108-12. PubMed ID: 16734634
    [Abstract] [Full Text] [Related]

  • 24. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 25. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 26. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 27. Pre-transplant mechanical ventilation increases short-term morbidity and mortality in pediatric patients with cystic fibrosis.
    Elizur A, Sweet SC, Huddleston CB, Gandhi SK, Boslaugh SE, Kuklinski CA, Faro A.
    J Heart Lung Transplant; 2007 Feb; 26(2):127-31. PubMed ID: 17258145
    [Abstract] [Full Text] [Related]

  • 28. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S.
    Transplantation; 2007 Apr 15; 83(7):912-8. PubMed ID: 17460562
    [Abstract] [Full Text] [Related]

  • 29. A rare case of plasmacytoma-like post-transplant lymphoproliferative disorder presenting in the skin of a lung transplant patient.
    McFarlane R, Hurst S, Sabath D, George E, Argenyi Z.
    J Cutan Pathol; 2008 Jun 15; 35(6):599-602. PubMed ID: 18201236
    [Abstract] [Full Text] [Related]

  • 30. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
    Knoop C, Kentos A, Remmelink M, Garbar C, Goldman S, Feremans W, Estenne M.
    Clin Transplant; 2006 Jun 15; 20(2):179-87. PubMed ID: 16640524
    [Abstract] [Full Text] [Related]

  • 31. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 32. Nasal polyposis in lung transplant recipients with cystic fibrosis.
    Vital D, Holzmann D, Boehler A, Hofer M.
    J Cyst Fibros; 2013 May 15; 12(3):266-70. PubMed ID: 22998935
    [Abstract] [Full Text] [Related]

  • 33. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
    Katz BZ, Pahl E, Crawford SE, Kostyk MC, Rodgers S, Seshadri R, Proytcheva M, Pophal S.
    Pediatr Transplant; 2007 Feb 15; 11(1):58-65. PubMed ID: 17239124
    [Abstract] [Full Text] [Related]

  • 34. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
    Fernández MC, Bes D, De Dávila M, López S, Cambaceres C, Dip M, Imventarza O.
    Pediatr Transplant; 2009 May 15; 13(3):307-10. PubMed ID: 18346039
    [Abstract] [Full Text] [Related]

  • 35. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
    Dharnidharka VR, Stevens G.
    Pediatr Transplant; 2005 Oct 15; 9(5):622-6. PubMed ID: 16176420
    [Abstract] [Full Text] [Related]

  • 36. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 37. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
    Faro A, Shepherd R, Huddleston CB, Lowell J, Gandhi S, Nadler M, Sweet SC.
    Transplantation; 2007 Jun 15; 83(11):1435-9. PubMed ID: 17565316
    [Abstract] [Full Text] [Related]

  • 38. [Specific complications after lung transplantation for cystic fibrosis].
    Allard-Recoque C, Bertocchi M, Mornex JF.
    Rev Pneumol Clin; 2002 Dec 15; 58(6 Pt 1):307-10. PubMed ID: 12545130
    [Abstract] [Full Text] [Related]

  • 39. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R.
    Australas Radiol; 2006 Oct 15; 50(5):412-8. PubMed ID: 16981935
    [Abstract] [Full Text] [Related]

  • 40. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute.
    Hou HA, Yao M, Tang JL, Chen YK, Ko BS, Huang SY, Tien HF, Chang HH, Lu MY, Lin TT, Lin KH, Hsiao CH, Lin CW, Chen YC.
    Bone Marrow Transplant; 2009 Feb 15; 43(4):315-21. PubMed ID: 18836488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.